The influence of drug-like concepts on decision-making in medicinal chemistry
The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development. However, despite this acceptance, analysis of recent trends reveals that the physical properties of molecules that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compounds in clinical development. The consequences of the marked increase in lipophilicity--the most important drug-like physical property--include a greater likelihood of lack of selectivity and attrition in drug development. Tackling the threat of compound-related toxicological attrition needs to move to the mainstream of medicinal chemistry decision-making.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1679]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 1×
“Overall oral bioavailability depends not just on absorption but also on dissolution, gut transit time and first-pass metabolism, so it is perhaps surprising that rat bioavailability can be categorized by simple physical properties such as PSA and rotatable bond”
BackgroundLead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199 · cited 1×
“jpg" NDATA ITEM> ]> Ten years have passed since the publication of the 'rule of five' physical property guidelines for drug permeabilit”
BackgroundCan the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Budavari, S. (1998) · Royal Society of Chemistry eBooks · Cited by 2,741
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Martin, Y. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492002 · Cited by 1,020 · cited 1×
“, and number of rule-of-five violations, PSA and ionization stat”
BackgroundQuantitative approach to biochemical structure-activity relationships
Hansch, C. (1969) · Accounts of Chemical Research · doi:10.1021/ar50020a002 · Cited by 918 · cited 1×
“This is not surprising: the role of LogP in influencing drug potency, pharmacokinetics and toxicity has been established for many year”
BackgroundMolecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877 · cited 1×
“This allows the processes of chemical optimization, which frequently increase physical propertie”
BackgroundThe Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811 · cited 1×
“Drugs and research compounds also differ in physicochemical properties between target protein classe”
BackgroundIs There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769 · cited 1×
“This allows the processes of chemical optimization, which frequently increase physical propertie”
BackgroundSelf-citationAbraham, M. H., Chadha, H. S., Whiting, G. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830806 · Cited by 766
Structure-based maximal affinity model predicts small-molecule druggability
Cheng, A. C., Coleman, R. G., Smyth, K. T., Cao, Q., Soulard, P., Caffrey, D. R., Salzberg, A. C., & Huang, E. S. (2007) · Nature Biotechnology · doi:10.1038/nbt1273 · Cited by 695 · cited 1×
“Factors driving the increases in physical properties in the most recently discovered oral drugs include a greater number of apparently less druggable new target”
BackgroundProperty-Based Design: Optimization of Drug Absorption and Pharmacokinetics
van de Waterbeemd, H., Smith, D. A., Beaumont, K., & Walker, D. K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000407e · Cited by 599
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Self-citationDruggability Indices for Protein Targets Derived from NMR-Based Screening Data
Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 522 · cited 1×
“Factors driving the increases in physical properties in the most recently discovered oral drugs include a greater number of apparently less druggable new target”
BackgroundCan we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
The role of the medicinal chemist in drug discovery — then and now
Lombardino, J. G., & Lowe, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1523 · Cited by 452
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Bender, A., Scheiber, J., Glick, M., Davies, J. W., Azzaoui, K., Hamon, J., Urban, L., Whitebread, S., & Jenkins, J. L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700026 · Cited by 327 · cited 1×
“It is time the medicinal chemistry community used its undoubted creative ability to better control physical properties, and to tackle the threat of compound-related toxicological attritio”
BackgroundTime-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Self-citationBooth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
Hou, T., & Xu, X. (2002) · Journal of Molecular Modeling · doi:10.1007/s00894-002-0101-1 · Cited by 255
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600343x · Cited by 228 · cited 1×
“are consistent with the rule of five, and recent studies on drug absorption have also highlighted the importance of polar surface area (PSA), which is closely correlated to O plus N atom count, and LogD (1-octanol–water coefficient at various pH values”
BackgroundThe Physicochemical Challenges of Designing Multiple Ligands
Morphy, R., & Rankovic, Z. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603015 · Cited by 194
Current trends in lead discovery: Are we looking for the appropriate properties?
Oprea, T. I. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020877402759 · Cited by 193
Hou, T., Wang, J., Zhang, W., & Xu, X. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6003515 · Cited by 178 · cited 1×
“However, these models do not readily explain human bioavailability dat”
BackgroundPredicting ADME properties and side effects: the BioPrint approach.
Krejsa, C. M., Horvath, D., Rogalski, S. L., Penzotti, J. E., Mao, B., Barbosa, F., & Migeon, J. (2003) · PubMed · Cited by 176
Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
Azzaoui, K., Hamon, J., Faller, B., Whitebread, S., Jacoby, E., Bender, A., Jenkins, J. L., & Urban, L. (2007) · ChemMedChem · doi:10.1002/cmdc.200700036 · Cited by 176 · cited 1×
“Although promiscuity will be less important if selectivity for the desired target is high, the lesson from this analysis is that the risk of unwanted pharmacology increases with lipophilicity and is dependent on ionization clas”
BackgroundInfluence of Molecular Flexibility and Polar Surface Area Metrics on Oral Bioavailability in the Rat
Lu, J. J., Crimin, K., Goodwin, J. T., Crivori, P., Orrenius, C., Xing, L., Tandler, P. J., Vidmar, T. J., Amore, B. M., Wilson, A. G. E., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306529 · Cited by 169 · cited 1×
“Overall oral bioavailability depends not just on absorption but also on dissolution, gut transit time and first-pass metabolism, so it is perhaps surprising that rat bioavailability can be categorized by simple physical properties such as PSA and rotatable bond”
BackgroundFragment screening: an introduction
Leach, A. R., Hann, M. M., Burrows, J. N., & Griffen, E. J. (2006) · Molecular BioSystems · doi:10.1039/b610069b · Cited by 163 · cited 1×
“Ligand efficiency (LE) is an important new concept, which estimates the efficiency of a binding interaction with respect to the magnitude of ligand physical properties, most notably size (equation 1”
BackgroundA quantitative assessment of hERG liability as a function of lipophilicity
Waring, M. J., & Johnstone, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.061 · Cited by 159 · cited 1×
“Lipophilic bases can cause cardiovascular toxicological effects by binding to the HERG (human ether-a-go-go-related potassium channel protein; also known as KCNH2) ion channe”
BackgroundAnalysis of drug-induced effect patterns to link structure and side effects of medicines
Fliri, A. F., Loging, W. T., Thadeio, P. F., & Volkmann, R. A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio747 · Cited by 158 · cited 1×
“asp">Cerep BioPrint database of drugs and reference compounds provides a unique opportunity to examine the role of physical properties in influencing drug promiscuity and side effect”
BackgroundKim, D., Wang, L., Hale, J. J., Lynch, C. L., Budhu, R. J., MacCoss, M., Mills, S. G., Malkowitz, L., Gould, S. L., DeMartino, J. A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.030 · Cited by 152
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
The evolution of synthetic oral drug properties
Proudfoot, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.024 · Cited by 129
Morphy, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512185 · Cited by 123
Organic Chemistry in Drug Discovery
MacCoss, M., & Baillie, T. A. (2004) · Science · doi:10.1126/science.1096800 · Cited by 118 · cited 1×
“, their ability to handle vastly increased data flo”
BackgroundIn Silico ADMET Traffic Lights as a Tool for the Prioritization of HTS Hits
Lobell, M., Hendrix, M., Hinzen, B., Keldenich, J., Meier, H., Schmeck, C., Schohe-Loop, R., Wunberg, T., & Hillisch, A. (2006) · ChemMedChem · doi:10.1002/cmdc.200600168 · Cited by 110
Components of Successful Lead Generation
Davis, A., Keeling, D., Steele, J., Tomkinson, N. P., & Tinker, A. C. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828411 · Cited by 110
Dependence of Molecular Properties on Proteomic Family for Marketed Oral Drugs
Vieth, M., & Sutherland, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603825 · Cited by 103 · cited 1×
“Drugs and research compounds also differ in physicochemical properties between target protein classe”
BackgroundPrediction of a new drug's potential to cause idiosyncratic reactions.
Uetrecht, J. (2001) · PubMed · Cited by 90
The Role of Hydrophobicity in Toxicity Prediction
Cronin, M. (2006) · Current Computer - Aided Drug Design · doi:10.2174/157340906778992346 · Cited by 86 · cited 1×
“This is not surprising: the role of LogP in influencing drug potency, pharmacokinetics and toxicity has been established for many year”
BackgroundDrug-like properties: guiding principles for design – or chemical prejudice?
Leeson, P. D., Davis, A. M., & Steele, J. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.005 · Cited by 82
Self-citationOvercoming HERG affinity in the discovery of the CCR5 antagonist maraviroc
Price, D. A., Armour, D. R., de Groot, M. J., Leishman, D. J., Napier, C. M., Perros, M., Stammen, B., & Wood, A. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.012 · Cited by 77
Computational Prediction of Oral Drug Absorption Based on Absorption Rate Constants in Humans
Linnankoski, J., Mäkelä, J. M., Ranta, V., Urtti, A. O., & Yliperttula, M. L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051231p · Cited by 76 · cited 1×
“are consistent with the rule of five, and recent studies on drug absorption have also highlighted the importance of polar surface area (PSA), which is closely correlated to O plus N atom count, and LogD (1-octanol–water coefficient at various pH values”
BackgroundJacoby, E., Schuffenhauer, A., Popov, M., Azzaoui, K., Havill, B., Schopfer, U., Engeloch, C., Staněk, J., Acklin, P., Rigollier, P., et al. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828376 · Cited by 76
Degradative transport of cationic amphiphilic drugs across phospholipid bilayers
Baciu, M., Sébaï, S. C., Ces, O., Mulet, X., Clarke, J. A., Shearman, G. C., Law, R. V., Templer, R. H., Plisson, C., Parker, C. A., et al. (2006) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2006.1842 · Cited by 67 · cited 1×
“and tissue toxicity by promoting cellular phospholipidosis”
BackgroundTute, M. S. (1971) · PubMed · Cited by 64
Predicting Oral Absorption and Bioavailability
Waterbeemd, H. V. D., & Jones, B. (2003) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(02)41001-6 · Cited by 44
Blake, J. F. (2005) · Medicinal Chemistry · doi:10.2174/157340605774598081 · Cited by 43
Makara, G. M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0700316 · Cited by 31
The Hit‐to‐Lead Process at Schering AG: Strategic Aspects
Steinmeyer, A. (2005) · ChemMedChem · doi:10.1002/cmdc.200500031 · Cited by 28
Cumming, J. G., Brown, S. J., Cooper, A. E., Faull, A. W., Flynn, A. P., Grime, K., Oldfield, J., Shaw, J. S., Shepherd, E., Tucker, H., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.089 · Cited by 19
Knowledge and Intelligence in Drug Design
Hopkins, A. L., & Polinsky, A. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41029-0 · Cited by 14 · cited 1×
“Perhaps these strategic developments, which clearly emphasise 'small is beautiful,' have yet to be fully accepted or implemented? Medicinal chemists will additionally be influenced by other factors in their decision-making: their and their colleague's knowledge and experienc”
BackgroundBeaumont, K. C., Schmid, E. F., & Smith, D. A. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.042 · Cited by 12
Lead Generation: Sowing the Seeds for Future Success
Bleicher, K., Nettekoven, M. H., Peters, J., & Wyler, R. (2004) · CHIMIA International Journal for Chemistry · doi:10.2533/000942904777677542 · Cited by 9
Research works printed but not linked: 3
- Kubinyi, H. Lipophilicity and biological activity. Drug transport and drug distribution in model systems and in biological systems. Arzn. Forsch. 29, 1067–1080 (1979).
- Wood, A. Annual Reports in Medicinal Chemistry Volume 41 503–522 (Academic Press, Burlington, 2006).
- Gray, N. Changing Landscapes: A Special Report on the World's Top 50 Pharma Companies. Pharmaceutical Executive web site [online] , (2006)
Cited by
Fluorine in medicinal chemistry
Purser, S., Moore, P. R., Swallow, S., & Gouverneur, V. (2008) · Chem. Soc. Rev. · doi:10.1039/b610213c · Cited by 7,570
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
Rings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
“The complete weighted QED is given in equation (4), where W is the weighting for each respective desirability function:”
Metadata
- Authors
- Leeson, P. D., & Springthorpe, B.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Leeson, Paul D.
- ORCID
- Leeson, Paul D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-11
- Volume
- 6
- Issue
- 11
- Pages
- 881-890
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2062458432
- Cited by
- 2,403
- References
- 60
- Citations by year
- 2026: 143 · 2025: 113 · 2024: 140 · 2023: 127 · 2022: 104 · 2021: 144 · 2020: 105 · 2019: 146 · 2018: 119 · 2017: 140 · 2016: 145 · 2015: 140 · 2014: 151 · 2013: 160 · 2012: 165
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AstraZeneca
- Merck
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- drug-likeness, Lipinski's rule of five, lipophilicity, drug attrition, drug discovery, drug selectivity
- MeSH terms
- Chemistry, Pharmaceutical, Decision Making, Pharmaceutical Preparations, Humans, Water, 1-Octanol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.